Prestige Consumer Healthcare Inc (PBH) Receives $34.80 Consensus Target Price from Analysts

Share on StockTwits

Prestige Consumer Healthcare Inc (NYSE:PBH) has been assigned an average recommendation of “Hold” from the five research firms that are covering the firm, MarketBeat reports. Two research analysts have rated the stock with a sell rating and three have assigned a hold rating to the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $34.80.

Several research analysts recently commented on PBH shares. Zacks Investment Research raised Prestige Consumer Healthcare from a “hold” rating to a “buy” rating and set a $35.00 price target for the company in a research report on Wednesday, January 2nd. Raymond James lowered Prestige Consumer Healthcare from an “outperform” rating to a “market perform” rating and set a $28.40 target price on the stock. in a research note on Tuesday, January 15th. DA Davidson increased their target price on Prestige Consumer Healthcare to $38.00 and gave the stock a “neutral” rating in a research note on Monday, November 5th. Finally, ValuEngine lowered Prestige Consumer Healthcare from a “hold” rating to a “sell” rating in a research note on Friday, November 16th.

In other Prestige Consumer Healthcare news, EVP Timothy Connors sold 74,707 shares of Prestige Consumer Healthcare stock in a transaction dated Wednesday, November 14th. The stock was sold at an average price of $38.96, for a total transaction of $2,910,584.72. Following the transaction, the executive vice president now directly owns 95,382 shares of the company’s stock, valued at approximately $3,716,082.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 1.14% of the company’s stock.

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Arizona State Retirement System lifted its holdings in Prestige Consumer Healthcare by 1.1% during the 4th quarter. Arizona State Retirement System now owns 37,134 shares of the company’s stock worth $1,147,000 after buying an additional 400 shares during the period. Diversified Trust Co raised its position in shares of Prestige Consumer Healthcare by 7.8% in the 4th quarter. Diversified Trust Co now owns 7,925 shares of the company’s stock worth $245,000 after acquiring an additional 575 shares in the last quarter. PNC Financial Services Group Inc. raised its position in shares of Prestige Consumer Healthcare by 12.2% in the 4th quarter. PNC Financial Services Group Inc. now owns 5,798 shares of the company’s stock worth $179,000 after acquiring an additional 630 shares in the last quarter. First Hawaiian Bank raised its position in shares of Prestige Consumer Healthcare by 218.4% in the 4th quarter. First Hawaiian Bank now owns 1,210 shares of the company’s stock worth $37,000 after acquiring an additional 830 shares in the last quarter. Finally, FNY Investment Advisers LLC bought a new position in shares of Prestige Consumer Healthcare in the 4th quarter worth about $37,000.

NYSE PBH traded up $0.40 on Wednesday, reaching $27.91. The company had a trading volume of 6,073 shares, compared to its average volume of 703,913. Prestige Consumer Healthcare has a 52 week low of $26.25 and a 52 week high of $41.76. The company has a market capitalization of $1.42 billion, a PE ratio of 10.93, a P/E/G ratio of 1.60 and a beta of 0.91. The company has a current ratio of 2.28, a quick ratio of 1.34 and a debt-to-equity ratio of 1.49.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings results on Thursday, February 7th. The company reported $0.73 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.71 by $0.02. Prestige Consumer Healthcare had a return on equity of 11.85% and a net margin of 6.44%. The company had revenue of $241.40 million during the quarter, compared to the consensus estimate of $241.40 million. During the same period in the prior year, the company earned $0.70 earnings per share. The company’s revenue for the quarter was down 10.8% compared to the same quarter last year. As a group, sell-side analysts predict that Prestige Consumer Healthcare will post 2.76 earnings per share for the current fiscal year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.

Featured Story: Cost of Debt

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Cresud S.A.C.I.F. y A.  Rating Lowered to Hold at BidaskClub
Cresud S.A.C.I.F. y A. Rating Lowered to Hold at BidaskClub
Omnicom Group  Price Target Increased to $83.00 by Analysts at Citigroup
Omnicom Group Price Target Increased to $83.00 by Analysts at Citigroup
Rogers Communications  Upgraded by Zacks Investment Research to “Buy”
Rogers Communications Upgraded by Zacks Investment Research to “Buy”
MustangCoin  Price Hits $0.0138 on Top Exchanges
MustangCoin Price Hits $0.0138 on Top Exchanges
Tokenomy  Price Tops $0.0483 on Major Exchanges
Tokenomy Price Tops $0.0483 on Major Exchanges
Cantor Fitzgerald Reaffirms Hold Rating for Gartner
Cantor Fitzgerald Reaffirms Hold Rating for Gartner


Leave a Reply

 
© 2006-2019 Zolmax.